LIMITED STOCK AVAILABLEPRICES SHOWN WHERE AVAILABLE
DSIP

PERFORMANCE / SINGLE

DSIP

5MG · 10MG · 15MG
Important medical and research notice

This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.

Research Overview

Delta sleep-inducing peptide (DSIP), studied in sleep-architecture and stress-response research.

Available Strengths

  • 5MG (DS5)
  • 10MG (DS10)
  • 15MG (DS15)

Research Protocol

Reference gradual titration

PeriodDoseU-100 unitsVolume
Week 10.1 mg60.06 mL
Week 20.15 mg90.09 mL
Week 30.2 mg120.12 mL
Weeks 4–80.25 mg150.15 mL

Reconstitution

Water volume3 mLConcentration1.667 mg/mLAdministrationSubcutaneousFrequencyOnce daily, evening, 30–60 minutes before bedtimeCycle length4–8 weeks in the reference protocol with gradual titration, optionally extended to 12 weeks with periodic breaks.

≈1.67 mg/mL once reconstituted

  1. Draw 3.0 mL of bacteriostatic water per 5 mg vial.
  2. Inject slowly along the vial wall; swirl gently until dissolved.

Research context

Reported in the cited literature to promote deep non-REM sleep initiation and maintenance, and to attenuate ACTH/corticosterone release in response to stress.

Storage

−20°C, dry/dark conditions. 2–8°C, use within ~4 weeks; avoid freeze–thaw cycles.

Research Notes

  • For educational and research reference only. Not medical advice and not intended for unsupervised human use.

References

Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source